150 related articles for article (PubMed ID: 24637214)
1. Discovery of N-substituted 3-arylisoquinolone derivatives as antitumor agents originating from O-substituted 3-arylisoquinolines via [2,3] or [3,3] rearrangement.
Li B; Wang G; Xu Z; Zhang Y; Huang X; Zeng B; Chen K; Shi J; Wang H; Zhu W
Eur J Med Chem; 2014 Apr; 77():204-10. PubMed ID: 24637214
[TBL] [Abstract][Full Text] [Related]
2. Overman rearrangement and Pomeranz-Fritsch reaction for the synthesis of benzoazepinoisoquinolones to discover novel antitumor agents.
Li B; Wang G; Yang M; Xu Z; Zeng B; Wang H; Shen J; Chen K; Zhu W
Eur J Med Chem; 2013; 70():677-84. PubMed ID: 24215818
[TBL] [Abstract][Full Text] [Related]
3. Chemistry of Ecteinascidins. Part 5: An Additional Proof of Cytotoxicity Evaluation of Ecteinascidin 770 Derivatives.
Toyoshima R; Mori N; Suzuki T; Lowtangkitcharoen W; Suwanborirux K; Saito N
Chem Pharm Bull (Tokyo); 2016; 64(7):966-9. PubMed ID: 27373655
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and cytotoxicity of (+/-)-7,9-dideoxy-pancratistatin analogues.
Nieto-García O; Alonso R
Org Biomol Chem; 2013 Jan; 11(3):515-22. PubMed ID: 23207545
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluations of novel indenoisoquinolines as topoisomerase I inhibitors.
Zhang X; Wang R; Zhao L; Lu N; Wang J; You Q; Li Z; Guo Q
Bioorg Med Chem Lett; 2012 Jan; 22(2):1276-81. PubMed ID: 22079759
[TBL] [Abstract][Full Text] [Related]
6. Discovery of novel 1,5-benzodiazepine-2,4-dione derivatives as potential anticancer agents.
Chen Y; Le V; Xu X; Shao X; Liu J; Li Z
Bioorg Med Chem Lett; 2014 Aug; 24(16):3948-51. PubMed ID: 25017036
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of 3-arylisoquinolines as antitumor agents.
Cho WJ; Park MJ; Chung BH; Lee CO
Bioorg Med Chem Lett; 1998 Jan; 8(1):41-6. PubMed ID: 9871625
[TBL] [Abstract][Full Text] [Related]
8. Chemistry of ecteinascidins. Part 3: preparation of 2'-N-acyl derivatives of ecteinascidin 770 and evaluation of cytotoxicity.
Saktrakulkla P; Toriumi S; Tsujimoto M; Patarapanich C; Suwanborirux K; Saito N
Bioorg Med Chem; 2011 Aug; 19(15):4421-36. PubMed ID: 21752654
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of benzo[3,4]azepino[1,2-b]isoquinolin-9-ones from 3-arylisoquinolines via ring closing metathesis and evaluation of topoisomerase I inhibitory activity, cytotoxicity and docking study.
Van HT; Khadka DB; Yang SH; Le TN; Cho SH; Zhao C; Lee IS; Kwon Y; Lee KT; Kim YC; Cho WJ
Bioorg Med Chem; 2011 Sep; 19(18):5311-20. PubMed ID: 21873069
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and structure-activity relationships of new benzodioxinic lactones as potential anticancer drugs.
Romero M; Renard P; Caignard DH; Atassi G; Solans X; Constans P; Bailly C; Pujol MD
J Med Chem; 2007 Jan; 50(2):294-307. PubMed ID: 17228871
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of 5,6-dihydropyrrolo[2,1-a]isoquinolines featuring an intramolecular radical-oxidative cyclization of polysubstituted pyrroles, and evaluation of their cytotoxic activity.
Reyes-Gutiérrez PE; Camacho JR; Ramírez-Apan MT; Osornio YM; Martínez R
Org Biomol Chem; 2010 Oct; 8(19):4374-82. PubMed ID: 20672155
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and cytotoxic evaluation of novel indenoisoquinoline-substituted triazole hybrids.
Pham Thi T; Le Nhat TG; Ngo Hanh T; Luc Quang T; Pham The C; Dang Thi TA; Nguyen HT; Nguyen TH; Hoang Thi P; Van Nguyen T
Bioorg Med Chem Lett; 2016 Aug; 26(15):3652-7. PubMed ID: 27342752
[TBL] [Abstract][Full Text] [Related]
13. 5-Substituted [1]pyrindine derivatives with antiproliferative activity.
Kolb S; Goddard ML; Loukaci A; Mondésert O; Ducommun B; Braud E; Garbay C
Eur J Med Chem; 2010 Mar; 45(3):896-901. PubMed ID: 19969400
[TBL] [Abstract][Full Text] [Related]
14. Anti-tumor activity of novel biisoquinoline derivatives against breast cancers.
Jaiswal AS; Hirsch-Weil D; Proulx ER; Hong S; Narayan S
Bioorg Med Chem Lett; 2014 Oct; 24(20):4850-3. PubMed ID: 25240616
[TBL] [Abstract][Full Text] [Related]
15. [Synthesis and structure-activity relationship of N-(2-arylethyl) isoquinoline derivatives as anti-cancer agents].
Wang YX; Zhao WL; Bi CW; Li YB; Shao RG; Song DQ
Yao Xue Xue Bao; 2012 Feb; 47(2):200-5. PubMed ID: 22512031
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological activity of piperlongumine derivatives as selective anticancer agents.
Wu Y; Min X; Zhuang C; Li J; Yu Z; Dong G; Yao J; Wang S; Liu Y; Wu S; Zhu S; Sheng C; Wei Y; Zhang H; Zhang W; Miao Z
Eur J Med Chem; 2014 Jul; 82():545-51. PubMed ID: 24937186
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, cytotoxicities and DNA cleavage activities of dibenzoxepine and isoquinoline derivatives starting from dehydroabietylamine.
Liu CX; Lin ZX; Zhou AM
J Asian Nat Prod Res; 2016 Dec; 18(12):1169-1177. PubMed ID: 27696913
[TBL] [Abstract][Full Text] [Related]
18. Mild C(sp
Romo-Pérez A; Miranda LD; Chávez-Blanco AD; Dueñas-González A; Camacho-Corona MDR; Acosta-Huerta A; García A
Eur J Med Chem; 2017 Sep; 138():1-12. PubMed ID: 28641156
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of novel substituted purine derivatives and identification of the cell death mechanism.
Demir Z; Guven EB; Ozbey S; Kazak C; Atalay RC; Tuncbilek M
Eur J Med Chem; 2015 Jan; 89():701-20. PubMed ID: 25462277
[TBL] [Abstract][Full Text] [Related]
20. Discovery of antiglioma activity of biaryl 1,2,3,4-tetrahydroisoquinoline derivatives and conformationally flexible analogues.
Mohler ML; Kang GS; Hong SS; Patil R; Kirichenko OV; Li W; Rakov IM; Geisert EE; Miller DD
J Med Chem; 2006 Sep; 49(19):5845-8. PubMed ID: 16970409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
